Other technical consultancy
NORSE BIOTECH AS
Revenue 2024
NOK 351,000
Operating profit
NOK −434,000
Equity
NOK 2.1m
Incorporated
2015
Share capital
NOK 588,000
Key figures · 2024
Current ratio
0.30
Equity ratio
52.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -123.5% | |
| Net margin (%%) | -124.6% | |
| Return on assets (%%) | -10.9% | |
| Likviditet | ||
| Current ratio | 0.30 | |
| Working capital | −1.3m | |
| Soliditet | ||
| Equity ratio (%%) | 52.4% | |
| Debt-to-equity ratio | 0.91 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.